Extantia: Investment Portfolio & Startup News
Extantia
To add a bio or update investment portfolio click update information.
Investment Portfolio


Epoch Biodesign raises £9m in funding from lululemon and leading VCs for enzymatic nylon recycling
Epoch Biodesign develops enzymatic recycling technology that converts waste nylon materials back into their original chemical components. It enables manufacturers to produce new nylon without using virgin feedstock, helping apparel and automotive companies reduce reliance on raw materials.


Uplift360 raises a £6.4m seed round led by Extantia to recover and reuse high-value composite waste
Uplift360 develops chemical processes to recover and regenerate advanced composite materials. It enables aerospace and industrial companies to reuse high-value materials that would otherwise become waste.


AssetCool raises £10m Series A led by Energy Impact Partners to scale robotic grid upgrade technology globally
AssetCool develops robotic systems that apply advanced coatings to power lines, increasing grid capacity without replacing existing infrastructure.


Epoch Biodesign raises £14m Series A led by Extantia Capital to scale plastic-eating enzyme technology
Epoch Biodesign uses engineered enzymes to break down plastic waste into reusable chemical building blocks, enabling higher-quality recycling at industrial scale.


Modern Synthesis raises £4.5m seed extension led by Extantia to scale biomaterials for fashion
Modern Synthesis creates biomaterials by combining bacterial nanocellulose with natural fibres, producing durable alternatives to leather and synthetic fabrics for fashion brands.
- 2(12 months)
- extantia.com
More venture news
- 13 Nov 2026

JADEJADE secures £450k in funding led by GC Angels to help universities manage their international student recruitment agents
EquityHR - 10 Nov 2026

PlankyPlanky raises £6m in funding co-led by Innovation Global and Azimut to turn financial data into credit decisions
EquityFintech - 10 Nov 2026

AncepAncep raises £6m in funding led by Creandum to help insurance brokers cover the clients they’d normally turn down
EquityEnterprise